A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

NCT06522997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1222

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: BAY3283142
DRUG: Placebo

Sponsor

Bayer